Perioperative Atezolizumab With MVA-BN-Brachyury and PROSTVAC For Intermediate-Risk And High-Risk Localized Prostate Cancer
Condition: Prostate Adenocarcinoma Intervention: Combination Product: MVA-BN-Brachyury Sponsors: University of Utah; Bavarian Nordic; Genentech, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials